Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.62
+0.31 (2.02%)
At close: Dec 5, 2025, 4:00 PM EST
15.71
+0.09 (0.58%)
After-hours: Dec 5, 2025, 7:20 PM EST
Aurinia Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 77.84 | 5.75 | -78.02 | -108.18 | -180.97 | -102.68 | |
| Depreciation & Amortization | 19.45 | 19.45 | 11.65 | 2.71 | 2.76 | 1.37 | |
| Loss (Gain) From Sale of Investments | -10.82 | -12.73 | -12.14 | -1.57 | 0.66 | - | |
| Stock-Based Compensation | 16.9 | 31.6 | 45.31 | 32.3 | 31.24 | 17.45 | |
| Other Operating Activities | 9.55 | -5.12 | 5.35 | 2.03 | 10.24 | 9.48 | |
| Change in Accounts Receivable | 5.76 | -12.46 | -10.61 | 1.93 | -15.42 | -0.65 | |
| Change in Inventory | -6.08 | 0.48 | -15.87 | -9.07 | -5.64 | -13.93 | |
| Change in Accounts Payable | -6.66 | 0.86 | 1.24 | -0.79 | 4.08 | 13.62 | |
| Change in Unearned Revenue | 9.42 | 5.79 | 3.76 | 3.05 | - | - | |
| Change in Other Net Operating Assets | 4.77 | 10.78 | 15.86 | -1.93 | -4.65 | 5.48 | |
| Operating Cash Flow | 120.1 | 44.39 | -33.46 | -79.53 | -157.69 | -69.86 | |
| Capital Expenditures | -0.46 | -0.28 | -0.72 | -0.29 | -0.3 | -5.67 | |
| Sale (Purchase) of Intangibles | 0.23 | - | - | - | -1.2 | -1.68 | |
| Investment in Securities | 43.45 | 39.59 | 5.88 | -59.68 | -84.53 | -150.84 | |
| Other Investing Activities | 0 | -0.04 | -11.86 | -0.66 | -17.84 | - | |
| Investing Cash Flow | 43.21 | 39.26 | -6.71 | -60.63 | -103.87 | -158.19 | |
| Long-Term Debt Repaid | - | -11.99 | -10.03 | - | - | - | |
| Net Debt Issued (Repaid) | -12.68 | -11.99 | -10.03 | - | - | - | |
| Issuance of Common Stock | 15.01 | 9.27 | 7.17 | 3.47 | 221.11 | 194.38 | |
| Repurchase of Common Stock | -129.6 | -46.37 | -2.28 | -1.04 | - | - | |
| Financing Cash Flow | -127.27 | -49.09 | -5.13 | 2.43 | 221.11 | 194.38 | |
| Net Cash Flow | 36.05 | 34.56 | -45.3 | -137.73 | -40.45 | -33.67 | |
| Free Cash Flow | 119.64 | 44.11 | -34.18 | -79.82 | -158 | -75.53 | |
| Free Cash Flow Margin | 45.01% | 18.76% | -19.47% | -59.55% | -346.44% | -150.70% | |
| Free Cash Flow Per Share | 0.84 | 0.30 | -0.24 | -0.56 | -1.22 | -0.64 | |
| Cash Income Tax Paid | 3.82 | 2.18 | 0.5 | 1.98 | 0.26 | 0.26 | |
| Levered Free Cash Flow | 85.21 | 62.94 | -3.89 | -35.1 | -98.48 | -45.77 | |
| Unlevered Free Cash Flow | 87.98 | 65.96 | -2.16 | -35.1 | -98.48 | -45.77 | |
| Change in Working Capital | 7.2 | 5.45 | -5.61 | -6.82 | -21.63 | 4.52 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.